Catalyst Wire Dossier Catalyst Wire Dossier

TNX-102 SL Tablets

cyclobenzaprine · Tonix Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TNX-102 SL Tablets, covering 2024-12-11 to 2024-12-11. Get the full timeline:

Most recent: Clinical Trial Update: A 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromyalgia Patients [Phase 3]

See pricing